Clinical trial - apixaban and stroke
Clinical trials
ARISTOTLE (2011)
- apixaban is superior to warfarin in stroke prevention and lower bleeding
AVERROES (2011)
- apixaban is superior to ASA in stroke prevention and same bleeding risk
ARISTOTLE INR (2014)
- apixaban is superior to warfarin in stroke prevention and lower bleeding
AUGUSTUS (2019)
- apixaban monotherapy is superior to VKA or a combination of apixaban to ASA, regarding bleeding risk